OliX Pharmaceuticals Inc. announced that Dmitry Samarsky PhD has joined the company as Senior Vice President of Technology and Global Business Development. Dr. Samarsky is a widely recognized expert in oligonucleotide/RNAi technologies and therapeutics. Over the past 15 years he has presented at served as an advisor for and helped organize more than 100 academic and industry conferences related to RNA science and technology.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14,200 KRW | +0.42% | -1.59% | -2.61% |
1st Jan change | Capi. | |
---|---|---|
-2.61% | 170M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- A226950 Stock
- News OliX Pharmaceuticals, Inc
- Olix Pharmaceuticals, Inc. Names Dmitry Samarsky as SVP of Technology and Global Business Development